| Product Code: ETC12962811 | Publication Date: Apr 2025 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 | |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Angola Naltrexone Buprenorphine Market Overview |
3.1 Angola Country Macro Economic Indicators |
3.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, 2021 & 2031F |
3.3 Angola Naltrexone Buprenorphine Market - Industry Life Cycle |
3.4 Angola Naltrexone Buprenorphine Market - Porter's Five Forces |
3.5 Angola Naltrexone Buprenorphine Market Revenues & Volume Share, By Formulation Type, 2021 & 2031F |
3.6 Angola Naltrexone Buprenorphine Market Revenues & Volume Share, By Mechanism of Action, 2021 & 2031F |
3.7 Angola Naltrexone Buprenorphine Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Angola Naltrexone Buprenorphine Market Revenues & Volume Share, By Administration Method, 2021 & 2031F |
3.9 Angola Naltrexone Buprenorphine Market Revenues & Volume Share, By Patient Group, 2021 & 2031F |
4 Angola Naltrexone Buprenorphine Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about the benefits of naltrexone and buprenorphine in addiction treatment |
4.2.2 Government initiatives to combat substance abuse and improve healthcare infrastructure |
4.2.3 Growing prevalence of opioid addiction and related disorders |
4.3 Market Restraints |
4.3.1 Stringent regulatory requirements for prescribing and dispensing naltrexone and buprenorphine |
4.3.2 Limited accessibility to specialized healthcare facilities for addiction treatment |
4.3.3 High cost associated with naltrexone and buprenorphine treatment |
5 Angola Naltrexone Buprenorphine Market Trends |
6 Angola Naltrexone Buprenorphine Market, By Types |
6.1 Angola Naltrexone Buprenorphine Market, By Formulation Type |
6.1.1 Overview and Analysis |
6.1.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Formulation Type, 2021 - 2031F |
6.1.3 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Oral Tablet, 2021 - 2031F |
6.1.4 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual Film, 2021 - 2031F |
6.1.5 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Injectable Form, 2021 - 2031F |
6.1.6 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Implant, 2021 - 2031F |
6.1.7 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Combination Form, 2021 - 2031F |
6.2 Angola Naltrexone Buprenorphine Market, By Mechanism of Action |
6.2.1 Overview and Analysis |
6.2.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Receptor Modulation, 2021 - 2031F |
6.2.3 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Partial Agonist, 2021 - 2031F |
6.2.4 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Long-Acting Effect, 2021 - 2031F |
6.2.5 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Sustained Release, 2021 - 2031F |
6.2.6 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Dual Mechanism, 2021 - 2031F |
6.3 Angola Naltrexone Buprenorphine Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Opioid Dependence, 2021 - 2031F |
6.3.3 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Withdrawal Management, 2021 - 2031F |
6.3.4 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Relapse Prevention, 2021 - 2031F |
6.3.5 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Maintenance Therapy, 2021 - 2031F |
6.3.6 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Detoxification, 2021 - 2031F |
6.4 Angola Naltrexone Buprenorphine Market, By Administration Method |
6.4.1 Overview and Analysis |
6.4.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.4.3 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Sublingual, 2021 - 2031F |
6.4.4 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Injection, 2021 - 2031F |
6.4.5 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Subcutaneous, 2021 - 2031F |
6.4.6 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Oral, 2021 - 2031F |
6.5 Angola Naltrexone Buprenorphine Market, By Patient Group |
6.5.1 Overview and Analysis |
6.5.2 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Adults, 2021 - 2031F |
6.5.3 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Teenagers, 2021 - 2031F |
6.5.4 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Elderly, 2021 - 2031F |
6.5.5 Angola Naltrexone Buprenorphine Market Revenues & Volume, By Critical Patients, 2021 - 2031F |
6.5.6 Angola Naltrexone Buprenorphine Market Revenues & Volume, By All Ages, 2021 - 2031F |
7 Angola Naltrexone Buprenorphine Market Import-Export Trade Statistics |
7.1 Angola Naltrexone Buprenorphine Market Export to Major Countries |
7.2 Angola Naltrexone Buprenorphine Market Imports from Major Countries |
8 Angola Naltrexone Buprenorphine Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in prescribing naltrexone and buprenorphine |
8.2 Percentage increase in the number of addiction treatment centers offering naltrexone and buprenorphine therapy |
8.3 Patient retention rate in naltrexone and buprenorphine treatment programs |
9 Angola Naltrexone Buprenorphine Market - Opportunity Assessment |
9.1 Angola Naltrexone Buprenorphine Market Opportunity Assessment, By Formulation Type, 2021 & 2031F |
9.2 Angola Naltrexone Buprenorphine Market Opportunity Assessment, By Mechanism of Action, 2021 & 2031F |
9.3 Angola Naltrexone Buprenorphine Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Angola Naltrexone Buprenorphine Market Opportunity Assessment, By Administration Method, 2021 & 2031F |
9.5 Angola Naltrexone Buprenorphine Market Opportunity Assessment, By Patient Group, 2021 & 2031F |
10 Angola Naltrexone Buprenorphine Market - Competitive Landscape |
10.1 Angola Naltrexone Buprenorphine Market Revenue Share, By Companies, 2024 |
10.2 Angola Naltrexone Buprenorphine Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here